X0306 4 2017-01-04 0 0000827871 EAGLE PHARMACEUTICALS, INC. EGRX 0001469124 Tarriff Scott C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BLVD., SUITE 315 WOODCLIFF LAKE NJ 07677 1 1 0 0 CEO Stock Option (right to buy) 84.92 2017-01-04 4 A 0 200900 0.00 A 2027-01-03 Common Stock 200900 200900 D The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 4, 2018, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the issuer as of the applicable vesting date. /s/ David E. Riggs, Attorney-in-Fact 2017-01-06